TrialBMC cancer2017

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.

Kenya Kamimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.